Aug 03, 2022
1078:727
For every 727 shares held, investors received 1078. The price per share adjusted from $188.00 to $126.79.
The split itself did not change the total investment value.
Medigen Vaccine Biologics Corp. (TPEX:6547) operates in the Biotechnology industry.
Medigen Vaccine Biologics Corp. company overviewMedigen Vaccine Biologics Corp.'s most recent stock split was on August 3, 2022. It was a 1078-for-727 forward split, so shareholders received 1078 shares for every 727 they held.
Medigen Vaccine Biologics Corp. (TPEX:6547) has split its stock 6 times: a 301-for-292 split on October 14, 2015, a 718-for-707 split on July 12, 2016, a 207-for-205 split on June 2, 2017, a 119-for-118 split on November 21, 2019, a 49-for-48 split on September 24, 2020, and a 1078-for-727 split on August 3, 2022.
Medigen Vaccine Biologics Corp. has split its stock 6 times. This history records 6 forward splits between October 14, 2015 and August 3, 2022.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Medigen Vaccine Biologics Corp.'s 1078-for-727 split on August 3, 2022, every 727 shares became 1078 shares.
Medigen Vaccine Biologics Corp. has not announced a new split in our records. Its most recent split was on August 3, 2022, 4 years ago. Companies announce splits in advance, and any new TPEX:6547 split will appear on this page.
Already premium?